NOTE: This is an archived page and is no longer being updated. For up-to-date information on our work, please use the main navigation menu, or click here
Idiosyncrasies in our business landscape, once viewed as innocuous inconveniences, are now costing Canada substantially in lost opportunity. When a company interested in conducting clinical trials comes to Canada, it faces multiple challenges which can result in costs and delays, and ultimately discourage Clinical Trial investment in Canada.
HealthCareCAN‘s aim is to help clinical trial companies succeed and stay in Canada. Our goals are to: (1) halt and reverse the downward trend in clinical trial investments; (2) improve business practices as they pertain to clinical trial operations; and (3) create a stable, forward looking opportunity for clinical trials into the future.
Canada is not the only country to appreciate the benefits of clinical trials. Other countries organizing and competing for clinical trials – without compromising safety or quality – will win contracts from us. Global head offices sponsoring clinical trials will only invest in those countries that provide the best comparative return on investment for their increasingly scarce research dollars.
HealthCareCAN works in collaboration with partners to promote high-quality clinical research by sharing best practices, educational tools and resources, and promoting Canada as a world-leading destination for clinical trials, so that Canadians can continue to benefit from these innovative treatments.
The Canadian Clinical Trials Coordinating Centre (CCTCC) was created to implement an action plan – “To Your Health and Prosperity – An Action Plan to Help Attract More Clinical Trials to Canada.” – to strengthen and improve clinical trials in Canada and streamline processes for companies and researchers. The action plan includes nine key recommendations to improve the coordination of clinical trials in Canada, increase participation in trials, and strategically raise Canada’s profile among international companies.
The Network of Networks (N2) is a not-for-profit incorporated organization and an alliance of Canadian research networks and organizations working to enhance national clinical research capability and capacity.
Under the Memorandum of Understanding, HealthcareCAN and N2 facilitate joint goals in clinical research, particularly in the areas of education, advocacy, strategic coordination and alignment. N2 makes available a suite of compliant Standard Operating Procedures, education and training , and quality tools.
Hospital News | October 1, 2016
Driving Innovation in Healthcare - An Engine for Economic Growth and Prosperity
Speaking Notes for 2016 Pre-Budget Meeting with Minister of Finance | January 20, 2016
Clinician Scientists in Canada: Supporting Innovations in Patient Care Through Research
Royal College of Physicians and Surgeons of Canada | December 1, 2015
Association of Canadian Academic Healthcare Organizations | December 7, 2012
To Your Health & Prosperity: An Action Plan to Help Attract More Clinical Trials to Canada
Association of Canadian Academic Healthcare Organizations, Canadian Institutes of Health Research, Canada’s Research Based Pharmaceutical Companies | March 30, 2012
Towards an Action Plan: Proceedings & Implications from the 2011 Clinical Trials Summit
Association of Canadian Academic Healthcare Organizations | March 30, 2012
Starting the Conversation - Canadian Clinical Trials Summit
Association of Canadian Academic Healthcare Organizations & Clinical Trials Summit Steering Committee | September 15, 2011
